PI4K
PI4K (phosphatidylinositol 4-kinase) catalyzes the first committed steps for phosphatidylinositol 4,5-bisphosphate biosynthesis. It is associated with viral replication and cancer.
- Cat.No. 产品名称 Information
-
GC65454
UCT943
-
GC65309
GSK-F1
-
GC62109
MMV390048
-
GC39155
PI-273
PI-273, the first reversibly and specific phosphatidylinositol 4-kinase (PI4KIIα) inhibitor with an IC50 of 0.47 μM, can inhibit breast cancer cell proliferation, block the cell cycle and induce cell apoptosis.
-
GC38033
KDU731
-
GC32847
PI4KIIIbeta-IN-9
-
GC32381
BF738735
-
GC32199
T-00127_HEV1
-
GC32163
BQR-695 (NVP-BQR695)
An antimalarial compound
-
GC32118
KDU691
An antimalarial compound
-
GC30777
PI4KIIIbeta-IN-10
-
GC18164
UCB9608
UCB9608 是一种有效、选择性和口服活性的 PI4KIIIβ 抑制剂,IC50 为 11 nM,对 PI3KC2 α、β 和 γ 脂质激酶具有选择性。
-
GC13089
PIK-93
A PI4KIIIβ inhibitor
-
GC15508
PI4KIII beta inhibitor 3
PI4KIII beta inhibitor 3 是一种新型高效的 PI4KIIIβ 抑制剂,IC50 为 5.7 nM。